DELIVERY LOCATION
560076
DELIVERY LOCATION
560076
  1. Home >
  2. Medicine Info >
  3. Ciprolic 300 MG Tablet

Ciprolic 300 MG Tablet

Manufacturer
Cipla Ltd.
Composition
Allopurinol
Prescription
Required

Description

Ciprolic 300 MG Tablet is an antigout agent which is used to prevent gout attacks by reducing the uric acid production. It should be started at low doses and increase gradually. It is not recommended in the patients with the known history of allergy.

Uses of Ciprolic 300 MG Tablet

What is it prescribed for?

  • Gout

    Ciprolic 300 MG Tablet is used in the treatment of gout which is a type of arthritis that causes severe pain, redness, and tenderness in the joints.

  • Hyperuricemia Secondary to Chemotherapy

    Ciprolic 300 MG Tablet is used in lower the uric acid levels in patients receiving cancer chemotherapy.

  • Calcium Oxalate Calculi with Hyperuricosuria

    Ciprolic 300 MG Tablet is used to lower the uric acid levels and prevents the formation of calculi in the kidney.

Side effects

Major & minor side effects for Ciprolic 300 MG Tablet

  • Joint painsevere
  • Skin rashsevere
  • Nausea and Vomitingsevererare
  • Stomach painsevererare
  • Yellow colored eyes or skinsevererare
  • Dizzinesssevererare
  • Depressionsevererare
  • Loss of appetitesevererare
  • Change in tasterare
  • Blurred visionrare
SEVERE
Contact your doctor immediately if any of these symptoms are experienced on a regular basis.
RARE
Observed in a small fraction of population.
This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.

Highlights

Commonly asked questions for Ciprolic 300 MG Tablet

Onset of action

The effect of this medicine can be observed in 2 to 3 days.

Duration of effect

The effect of this medicine lasts for an average duration of 24 hours.

Safe with alcohol?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?

No habit forming tendencies were reported.

Usage in pregnancy?

This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

Usage while breast-feeding?

This medicine is known to excreted in breast milk. It is not recommended in breastfeeding women unless necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Monitoring of allergic reactions like skin rash and blood cell count is necessary.

Substitutes

List of substitutes for Ciprolic 300 MG Tablet

Below is the list of medicines, which have the same composition, strength and form as Ciprolic 300 MG Tablet, and hence can be used as its substitute.
Aloric 300 MG Tablet
Intas Pharmaceuticals Ltd.
Alrik 300 MG Tablet
Cipla Ltd.
Ciploric 300 MG Tablet
Cipla Ltd.
Zyloric 300 MG Tablet
Glaxosmithkline Pharmaceuticals Ltd.
Zyrik 300 MG Tablet
Cipla Ltd.

Find a doctor near you

Looking for a doctor?

Book an appointment with the top doctors near you.

When not to use?

Contraindications of Ciprolic 300 MG Tablet

  • Allergy

    Not recommended in patients with known allergy to Ciprolic 300 MG Tablet.

Dosage

  • Missed Dose

    Take the missed dose as soon as you remember. However, if it is almost time for the next scheduled dose then the missed dose should be skipped.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of overdose.

Interactions

All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

  • Description

    - Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Instructions

    - Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Interaction with Medicine

  • Azathioprinesevere
  • Antacidsmoderate
  • Angiotensin converting enzyme inhibitors (ACEI's)severe

Disease interactions

  • Bone marrow suppression

    moderate
    This medicine may decrease the blood cell production and increases the risk of infections and other serious condition. Frequent monitoring of blood cells level is necessary. Any signs of altered blood cell level should be reported to the doctor.

  • Impaired kidney function

    moderate
    This medicine should be used with caution in patients with existing kidney disease. The dose should be adjusted based on the CrCl.

Food interactions

  • Information not available.

Lab interactions

  • Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take Ciprolic 300 MG Tablet as advised by the doctor. Do not take this medicine in larger quantities than recommended. Drink adequate amount of water to prevent the formation of kidney stones. The treatment should be started at lower doses and increase the dose gradually based on the response. It is advised not to operate machinery and drive vehicle due to the risk of dizziness.

Warnings

Warnings for special population

  • Pregnancy

    - This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine.

  • Breast-feeding

    - This medicine is known to excreted in breast milk. It is not recommended in breastfeeding women unless necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Monitoring of allergic reactions like skin rash and blood cell count is necessary.

General warnings

  • Allergic reactions

    - This medicine should be discontinued immediately when allergy symptoms like skin rash, swelling of lips, and face appear.

  • Hydration

    - Drink adequate amount of water (2 liters/day) to increase the urine output and to prevent the formation of kidney stones.

  • Liver disease

    - This medicine is known to cause liver failure. Obtain baseline of liver function tests before initiation of the treatment. The treatment should be discontinued if any signs of any increase in the liver enzymes appear.

  • Asymptomatic hyperuricemia

    - This medicine is not recommended for use in the patients with asymptomatic hyperuricemia.

Other details

  • To be taken after food
  • To be taken as instructed by doctor
  • Does not cause sleepiness

How it works

It works by reducing the uric acid levels in the body.

Legal Status

Approved
Approved
Approved
Approved

Classification

Category
Antigout agents
Schedule
Schedule H

References

Chat with a doctor

Get reply within 5 mins

How will this medicine affect me?

Chat with verified doctors starting @ ₹99

Did you find this helpful?

Your feedback will help us improve the product

Thanks for your response
What can we improve?
Thanks for your response
Information on this page was last updated on 5 Jan 2018

Report an error

Oops! Seems like there is an error in your form. Make sure -
  1. Your email ID is correct.
  2. Your response is not blank.
  3. Your internet is working.
Thank you!
Your response is valuable to us.

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.